The effect of using assessment instruments on substance-abuse outpatients' adherence to treatment: A multi-centre randomised controlled trial

BMC Health Services Research

Volumn 11, Issue , 2011, Pages

  Raes, Veerle ^a   De Jong, Cor A J ^b   De Bacquer, Dirk ^c   Broekaert, Eric ^c   De Maeseneer, Jan ^c  

^a De Sleutel   (Belgium)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADDICTION; ARTICLE; BELGIUM; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEEDBACK SYSTEM; HEALTH SURVEY; HUMAN; INTERPERSONAL COMMUNICATION; MULTICENTER STUDY; NETHERLANDS; OUTPATIENT; PATIENT COMPLIANCE; PSYCHOMETRY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; RISK; STATISTICS;

BELGIUM; COMMUNICATION; CONFIDENCE INTERVALS; FEEDBACK; HEALTH STATUS INDICATORS; HUMANS; MEDICATION ADHERENCE; NETHERLANDS; OUTPATIENTS; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RISK; SUBSTANCE-RELATED DISORDERS;

EID: 80053310443     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-11-123     Document Type: Article

References (46)

1. Science is revolutionizing our view of addiction and what to do about it. A Leshner, FOCUS The Journal of Lifelong Learning in Psychiatry 2003 I 2 194 195
2. Have we evaluated addiction treatment correctly? Implications from a chronic care perspective. Editorial. A Mc Lellan, Addiction 2002 97 249 252 10.1046/j.1360-0443.2002.00127.x 11964098 (Pubitemid 34250719)
3. Drug dependence, a chronic medical illness. Implications for treatment, insurance, and outcomes evaluation. A Mc Lellan D Lewis CP O'Brien H Kleber, JAMA 2000 284 13 1689 1695 10.1001/jama.284.13.1689 11015800
4. Myths about the treatment of addiction. C O'Brien A Mc Lellan, Lancet 1996 347 237 240 10.1016/S0140-6736(96)90409-2 8551886 (Pubitemid 26035251)
5. Fixed and dynamic predictors of client retention in therapeutic communities. G De Leon, J Subst Abuse Treat 1993 10 11 16 10.1016/0740-5472(93) 90093-H 8383775 (Pubitemid 23128492)
6. The therapeutic community for addicts. Intimacy, parent involvement and treatment success. M Kooyman, Amsterdam: Swets & Zeitlinger 1993
7. The impact of a social network intervention on retention in Belgian therapeutic communities: a quasi-experimental study. V Soyez G De Leon Y Rosseel E Broekaert, Addiction 2006 101 1027 1034 10.1111/j.1360-0443.2006.01441.x 16771894 (Pubitemid 43847104)
8. Examining the relative importance of social context referents in predicting intention to change substance abuse behavior using EASE. H Matto K Miller C Spera, Addict Behav 2007 32 1826 1834 10.1016/j.addbeh.2006.12.015 17240077 (Pubitemid 47033958)
9. Therapeutic communities - enhancing retention in treatment using 'senior professor' staff. G De Leon J Hawke N Jainchill G Melnick, J Subst Abuse Treat 2000 19 375 382 10.1016/S0740-5472(00)00124-0 11166502 (Pubitemid 32112357)
10. What future for the therapeutic community in the field of addiction? A view from Europe. E Broekaert, Addiction 2006 101 1677 1678 17156161 (Pubitemid 44899684)
11. The effectiveness of the use of patient-based measures of health in routine practice in improving the process and outcomes of patient care: a literature overview. J Greenhalgh K Meadows, Journal of evaluation in clinical practice 1999 5 4 401 416 10.1046/j.1365-2753.1999.00209.x 10579704 (Pubitemid 29519188)
12. Patient-focused Research: Using Patient Outcome Data to Enhance Treatment Effects. M Lambert N Hansen A Finch, J Consult Clin Psychol 2001 69 2 159 172 11393594 (Pubitemid 32488275)
13. Effect of feedback of treatment outcome in specialist mental healthcare: meta-analysis. C Knaup M Koesters D Schoefer T Becker B Puschner, The British Journal of Psychiatry 2009 195 15 22 10.1192/bjp.bp.108.053967 19567889
14. Enhancing the validity and utility of randomized clinical trials in addictions treatment research: II. Participant samples and and assessment. F Del Boca J Darkes, Addiction 2007 102 1194 1203 10.1111/j.1360-0443.2007.01863.x 17511752 (Pubitemid 47037925)
15. Assessment may conceal therapeutic benefit: findings from randomized controlled trial for hazardous drinking. K Kypri JD Langley JB Saunders ML Cashell-Smith, Addiction 2006 102 62 70 (Pubitemid 46006472)
16. Improving the Effects of Psychotherapy: The Use of Early Identification of Treatment Failure and Problems-Solving Strategies in Routine Practice. J Whipple M Lambert D Vermeersch D Smart S Nielsen E Hawkins, J Counselling Psychol 2003 50 1 59 68 (Pubitemid 36138830)
17. Concurrent monitoring of psychological distress and satisfaction measures as predictors of addiction treatment retention. E Hawkins J Baer D Kivlahan, J Subst Abuse Treat 2008 35 207 216 10.1016/j.jsat.2007.10.001 18082998
18. Responsibilities in providing psychological test feedback to clients. K Pope, Psychological Assessment 1992 4 3 268 271
19. Brief psychotherapy and psychological assessments: entering a relationship, establishing a focus, and providing feedback. D Clair D Prendergast, Professional psychology: Research and Practice 1994 25 1 46 49
20. Therapeutic effects of providing MMPI-2 test feedback to college students awaiting therapy. S Finn M Tonsager, Psychological Assessment 1992 4 278 287
21. The revised CONSORT Statement for reporting randomized trials: explanation and elaboration. D Altman K Schulz D Moher M Egger F Davidoff D Elbourne P Gotzsche T Lang, Ann Intern Med 2001 134 8 663 694 11304107 (Pubitemid 32322245)
22. The consolidated standards of reporting trials (CONSORT). Guidelines for reporting randomized trials. J Bennett, Nurs Res 2005 54 2 128 132 15778654 (Pubitemid 40528990)
23. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. K Schulz D Altman D Moher, Ital J Public Health 2010 7 3 325 332
24. A Jadad, Randomised Controlled Trials. A user's guide Plymouth: Latimer Trend & Company Ltd 1998 21592376
25. A new design for randomized clinical trials. M Zelen, N Engl J Med 1979 300 1242 1245 10.1056/NEJM197905313002203 431682 (Pubitemid 9236327)
26. Randomized consent designs for clinical trials: an update. M Zelen, Stat Med 1990 9 645 656 10.1002/sim.4780090611 2218168 (Pubitemid 20235037)
27. Review of randomised trials using the post-randomised consent (Zelen's) design. J Adamson S Cockayne S Puffer D Torgerson, Contemp Clin Trials 2006 27 305 319 10.1016/j.cct.2005.11.003 16455306 (Pubitemid 43928877)
28. European adaptation of a multidimensional assessment instrument for drug and alcohol dependents. A Kokkevi C Hartgers, Eur Addict Res 1995 1 208 210 10.1159/000259089
29. The Addiction Severity Index: Reliability and validity in a Dutch addict population. V Hendriks C Kaplan J Van-Limbeek P Geerlings, J Subst Abuse Treat 1989 6 133 141 10.1016/0740-5472(89)90041-X 2746712 (Pubitemid 19150040)
30. EuropASI: A standard in De Sleutel, Belgium. V Raes G Lombaert, J Subst Use 2004 9 3-4 196 204 10.1080/14659890410001697514 (Pubitemid 38979477)
31. Development of a short 'readiness to change' questionnaire for use in brief, opportunistic interventions among excessive drinkers. S Rollnick N Heather R Gold W Hall, Br J Addict 1992 87 743 754 10.1111/j.1360-0443.1992. tb02720.x 1591525
32. Reliability and validity of the Dutch version of the Readiness to Change questionnaire. L De Fuentes-Merillas C de Jong G Schippers, Alcohol Alcohol 2000 37 93 99
33. The use of RCQ-D in patients with poly drug abuse. V Raes G De Weerdt-Van Oene M Velasquez J De Maeseneer C de Jong, Addict Res Theory 2010 18 4 409 420 10.3109/16066350903291066
34. H Küfner M Coenen W Indlekofer, PREDI Psychosoziale ressourcenorientierte Diagnostik. Ein problem- und lösungsorientierter Ansatz. [PREDI psycho-social resources oriented diagnostic system. A problem and solution oriented approach]. Version 3.0 Lengerich: Pabst Science Publishers 2006
35. Cross cultural adaptation of health measures. S Hunt J Alonso D Bucquet M Niero I Wiklund S McKenna, Health Policy 1991 19 33 44 10.1016/0168-8510(91) 90072-6 10117390
36. Measuring personal resources in a therapeutic community based treatment system: a reliability and validity study of the Dutch version of PREDI-Short Diagnosis. V Raes W Vanderplasschen M De Wilde S Delputte V Soyez E Broekaert, Ther Commun J 2009 30 4 344 365
37. Enhancing the validity and utility of randomized clinical trials in addictions treatment research: I. Treatment implementation and research design. F Del Boca J Darkes, Addiction 2007 102 1047 1056 10.1111/j.1360-0443.2007. 01862.x 17567393 (Pubitemid 46918675)
38. M Velasquez G Maurer C Crouch C Diclemente, Group treatment for substance abuse: a stages-of-change therapy manual [Dutch Translation by de Jong, CAJ & Verbrugge, CAG] Amsterdam: Harcourt Assessment 2006
39. S Lemeshow D Hosmer J Klar S Lwanga, Adequacy of Sample Size in Health Studies Chichester: Published on behalf of the World Health Organisation by John Wiley & Sons 1990
40. The network for the Improvement of Addiction Treatment (NIATx): Enhancing access and retention. D McCarty D Gustafson J Wisdom J Ford D Choi T Molfenter V Capoccia F Cotter, Drug Alcohol Depend 2007 88 138 145 10.1016/j.drugalcdep. 2006.10.009 17129680 (Pubitemid 46482819)
41. Practice review: Clinician interventions related to alliance during the initial interview and psychological assessment. M Hilsenroth T Cromer, Psychotherapy: theory, research, practice, training 2007 44 2 205 218 (Pubitemid 47444901)
42. Improving session attendance in mental health and substance abuse settings: a review of controlled studies. N Lefforge B Donohue M Strada, Behavior Therapy 2007 38 1 22 10.1016/j.beth.2006.02.009 17292691 (Pubitemid 46209063)
43. A survival analysis of clinically significant change in outpatient psychotherapy. E Anderson M Lambert, J Clin Psychol 2001 57 7 875 888 10.1002/jclp.1056 11406801 (Pubitemid 32566004)
44. Research into practice II. The need for research in primary care. J De Maeseneer M Van Driel L Green C Van Weel, The Lancet 2003 362 1314 1319 10.1016/S0140-6736(03)14576-X (Pubitemid 37324263)
45. Enhancing the validity and utility of randomized clinical trials in addictions treatment research: III. Data processing and statistical analysis. F Del Boca J Darkes, Addiction 2007 102 1356 1364 10.1111/j.1360-0443.2007.01864.x 17511751 (Pubitemid 47246978)
46. European Addiction Severity Index EuropASI. Guide for training and administering the EuropASI interview. P Blanken V Hendriks G Pozzi E Tempesta C Hartgers M Koeter E Fahrner B Gsellhofer H Küfner A Kokkevi, et al. European Commission: COST-A6 Working Group 4 1996